Loading...
Hepatitis C virus enters liver cells using the CD81 receptor complex proteins calpain-5 and CBLB.
Bruening, Janina Lasswitz, Lisa Banse, Pia Kahl, Sina Marinach, Carine Vondran, Florian W Kaderali, Lars Silvie, Olivier Pietschmann, Thomas Meissner, Felix
Bruening, Janina
Lasswitz, Lisa
Banse, Pia
Kahl, Sina
Marinach, Carine
Vondran, Florian W
Kaderali, Lars
Silvie, Olivier
Pietschmann, Thomas
Meissner, Felix
Citations
Altmetric:
Advisors
Editors
Other Contributors
Issue Date
2018-07-01
Submitted date
Files
Loading...
Open Access publication
Adobe PDF, 8.79 MB
Other Titles
Abstract
Hepatitis C virus (HCV) and the malaria parasite Plasmodium use the membrane protein CD81 to invade human liver cells. Here we mapped 33 host protein interactions of CD81 in primary human liver and hepatoma cells using high-resolution quantitative proteomics. In the CD81 protein network, we identified five proteins which are HCV entry factors or facilitators including epidermal growth factor receptor (EGFR). Notably, we discovered calpain-5 (CAPN5) and the ubiquitin ligase Casitas B-lineage lymphoma proto-oncogene B (CBLB) to form a complex with CD81 and support HCV entry. CAPN5 and CBLB were required for a post-binding and pre-replication step in the HCV life cycle. Knockout of CAPN5 and CBLB reduced susceptibility to all tested HCV genotypes, but not to other enveloped viruses such as vesicular stomatitis virus and human coronavirus. Furthermore, Plasmodium sporozoites relied on a distinct set of CD81 interaction partners for liver cell entry. Our findings reveal a comprehensive CD81 network in human liver cells and show that HCV and Plasmodium highjack selective CD81 interactions, including CAPN5 and CBLB for HCV, to invade cells.
Citation
Affiliation
Publisher
Journal
PubMed ID
PubMed Central ID
Additional Links
Embedded video
Type
Article
Language
Description
Series/Report no.
ISSN
1553-7374
EISSN
ISBN
ISMN
Gov't Doc #
Sponsors
License
Attribution-NonCommercial-ShareAlike 3.0 United States